We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
UK medicines regulator issues its first authorisation under Project Orbis for Osimertinib (Tagrisso), a post-surgery treatment for lung cancer.
Dr Alison Cave joins the Medicines and Healthcare products Regulatory Agency (MHRA) as Chief Safety Officer
Women from under-represented groups urged to respond to call for evidence to shape the future of women’s healthcare.
First published during the 2019 to 2022 Johnson Conservative government
This letter sets out the changes to the Pneumococcal Polysaccharide Vaccine (PPV) supply route from 1 June 2021.
The UK will host a fund-raising summit in 2022 to support the work of the Coalition for Epidemic Preparedness Innovations.
Health and Social Care Secretary Matt Hancock spoke at the United Nations high-level interactive dialogue on antimicrobial resistance (AMR).
The Health and Social Care Secretary lays out the government's commitment to boost the UK life sciences sector and build on lessons from the pandemic.
The Secretary of State for Health and Social Care Matt Hancock spoke at the Association of the British Pharmaceutical Industry (ABPI) annual conference.
Barriers to Research working group calls for written evidence about barriers to legitimate research for controlled drugs, excluding synthetic cannabinoids.
The Antivirals Taskforce will identify treatments for UK patients who have been exposed to COVID-19 to stop the infection spreading and speed up recovery time.
Professor Lucy Chappell FMedSci has been appointed as the next Chief Scientific Adviser for the Department of Health and Social Care.
Today we are publishing the findings of a dialogue with more than 100 members of the public about how to make sure health and care data is used in ways that benefit people and society.
NHS Test and Trace is providing additional testing across parts of South London where the variant first identified in South Africa has been found.
Recommendations include the launch of a new traffic light system and 'green watchlist', and the introduction of travel certification.
An introductory blog from Dr Nicola Byrne, the new National Data Guardian for Health and Social Care in England.
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk of specific types of blood clots because of their medical condition.
Following suspensions by some countries of the COVID-19 Vaccine AstraZeneca over suspected blood clots, the MHRA confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go…
The MHRA is committed to speeding up access to innovative new medicines for patients.
Care home residents to be allowed a second regular visitor indoors, with tests required before entry and PPE provided.
Minister of State for Health Edward Argar spoke at the NHS England and NHS Improvement National Estates and Facilities Forum about a refresh of the Health Infrastructure Plan.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).